Scientific Session
Systemic Lupus Erythematosus (SLE)
David Karp, MD,PhD
UT Southwestern Medical Center
Dallas, Texas, United States
Disclosure(s): Ampel: Consultant (Terminated, March 20, 2025); Biogen: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Caribou: Consultant (Ongoing); Celgene: Grant/Research Support (Terminated, March 20, 2025); Eli Lilly: Grant/Research Support (Terminated, March 20, 2025); Novartis: Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing); UCB: Grant/Research Support (Ongoing); Zura: Consultant (Ongoing)